Presentation to motivate healthcare professionals (HCPs) to include strategies for recognising and mitigating the impact of OFF state episodes on the daily lives of people living with Parkinsons and their caregivers.
We are a highly successful and rapidly growing speciality pharmaceutical company engaged in the development and commercialisation of innovative medicines for the treatment of unmet therapeutic needs.
Kyowa Kirin aims to contribute to the health and comfort of people around the world. Our mission is to respond to the needs of patients suffering from diseases for which no effective treatments are available, their families and the healthcare professionals fighting those diseases on the front line. Specialising in the core fields of oncology, nephrology, immunology / allergy and the central nervous system, we develop leading-edge biotechnologies, focusing on the use of antibodies, to develop and discover innovative new drugs, which Kyowa Kirin market worldwide.